Reduced serum osteocalcin concentrations are associated with type 2 diabetes mellitus and the metabolic syndrome components in postmenopausal women: the crosstalk between bone and energy metabolism
- PMID: 22752126
- DOI: 10.1007/s00774-012-0367-z
Reduced serum osteocalcin concentrations are associated with type 2 diabetes mellitus and the metabolic syndrome components in postmenopausal women: the crosstalk between bone and energy metabolism
Abstract
Although it has been shown that osteocalcin functions as a hormone in the regulation of glucose metabolism and fat mass, no population-based study to date has addressed serum osteocalcin levels in relation to energy metabolism concurrent with bone metabolism in postmenopausal women. In a population-based study, cardiovascular risk factors, high-sensitivity C-reactive protein (hs-CRP), osteoprotegerin, receptor activator of nuclear factor-κB ligand, osteocalcin, CrossLaps, alkaline phosphatase, and bone mineral density (BMD) at the lumbar spine (L2-L4) and the proximal femur were measured in 382 Iranian postmenopausal women. In multiple logistic regression analysis, lower osteocalcin and CrossLaps levels were associated with a higher odds ratio (OR) of having type 2 diabetes mellitus when adjustments were made for age, hs-CRP, cardiovascular risk factors, BMD, and markers of bone metabolism [OR 5.17, CI (2.66-10.04), p < 0.0001 and OR 2.51, CI (1.37-4.61), p = 0.003, respectively]. However, lower alkaline phosphatase levels were associated with a lower OR of having type 2 diabetes mellitus [OR 0.28, CI (0.15-0.52), p < 0.0001] in regression analysis. No significant difference was found between serum osteocalcin levels of those with and without metabolic syndrome. Among the metabolic syndrome components, low osteocalcin levels had significant associations with elevated blood glucose [OR 1.89, CI (1.16-3.07), p = 0.010] and elevated waist circumference [OR 2.53, CI (1.13-5.67), p = 0.024] in multivariate analyses. In conclusion, serum osteocalcin was independently associated with glucose intolerance and abdominal obesity as the components of metabolic syndrome and type 2 diabetes mellitus in postmenopausal women. Since CrossLaps and alkaline phosphatase levels were independently associated with the presence of type 2 diabetes mellitus, the unique contribution of osteocalcin in glucose metabolism could not be concluded.
Similar articles
-
Bone Mineral Density in Relation to Metabolic Syndrome Components in Postmenopausal Women With Diabetes Mellitus Type 2.Acta Clin Croat. 2017 Mar;56(1):58-63. doi: 10.20471/acc.2017.56.01.09. Acta Clin Croat. 2017. PMID: 29120134
-
The relationship between the metabolic syndrome and its components and bone status in postmenopausal women.Acta Physiol Hung. 2014 Jun;101(2):216-27. doi: 10.1556/APhysiol.101.2014.2.10. Acta Physiol Hung. 2014. PMID: 24901081
-
Relationships among serum receptor of nuclear factor-kappaB ligand, osteoprotegerin, high-sensitivity C-reactive protein, and bone mineral density in postmenopausal women: osteoimmunity versus osteoinflammatory.Menopause. 2009 Sep-Oct;16(5):950-5. doi: 10.1097/gme.0b013e3181a181b8. Menopause. 2009. PMID: 19387415
-
Association of serum total osteocalcin with type 2 diabetes and intermediate metabolic phenotypes: systematic review and meta-analysis of observational evidence.Eur J Epidemiol. 2015 Aug;30(8):599-614. doi: 10.1007/s10654-015-0058-x. Epub 2015 Jun 18. Eur J Epidemiol. 2015. PMID: 26085114 Review.
-
The role of bone in energy metabolism: A focus on osteocalcin.Bone. 2024 Nov;188:117238. doi: 10.1016/j.bone.2024.117238. Epub 2024 Aug 15. Bone. 2024. PMID: 39153587 Review.
Cited by
-
Thyroid and bone turnover markers in type 2 diabetes: results from the METAL study.Endocr Connect. 2022 Mar 31;11(3):e210484. doi: 10.1530/EC-21-0484. Endocr Connect. 2022. PMID: 35196256 Free PMC article.
-
Prevalence of Metabolic Syndrome and Its Components in the Iranian Adult Population: A Systematic Review and Meta-Analysis.Iran Red Crescent Med J. 2015 Dec 27;17(12):e24723. doi: 10.5812/ircmj.24723. eCollection 2015 Dec. Iran Red Crescent Med J. 2015. PMID: 26756015 Free PMC article. Review.
-
The effects of exenatide and insulin glargine treatments on bone turnover markers and bone mineral density in postmenopausal patients with type 2 diabetes mellitus.Medicine (Baltimore). 2023 Sep 29;102(39):e35394. doi: 10.1097/MD.0000000000035394. Medicine (Baltimore). 2023. PMID: 37773814 Free PMC article. Clinical Trial.
-
Circulating Undercarboxylated Osteocalcin as Estimator of Cardiovascular and Type 2 Diabetes Risk in Metabolic Syndrome Patients.Sci Rep. 2020 Feb 4;10(1):1840. doi: 10.1038/s41598-020-58760-7. Sci Rep. 2020. PMID: 32020009 Free PMC article.
-
Undercarboxylated Osteocalcin: Experimental and Human Evidence for a Role in Glucose Homeostasis and Muscle Regulation of Insulin Sensitivity.Nutrients. 2018 Jun 29;10(7):847. doi: 10.3390/nu10070847. Nutrients. 2018. PMID: 29966260 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous